113 related articles for article (PubMed ID: 6303353)
1. Inhibition of lymphocyte function by 9-deazaadenosine.
Zimmerman TP; Deeprose RD; Wolberg G; Stopford CR; Duncan GS; Miller WH; Miller RL; Lim MI; Ren WY; Klein RS
Biochem Pharmacol; 1983 Apr; 32(7):1211-7. PubMed ID: 6303353
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: evidence for a methylation reaction essential to cytolysis.
Zimmerman TP; Wolberg G; Duncan GS
Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6220-4. PubMed ID: 216017
[TBL] [Abstract][Full Text] [Related]
3. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
Wolberg G; Zimmerman TP
Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
[TBL] [Abstract][Full Text] [Related]
4. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
Glazer RI; Hartman KD; Knode MC
Mol Pharmacol; 1983 Sep; 24(2):309-15. PubMed ID: 6888372
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
Duncan GS; Wolberg G; Schmitges CJ; Deeprose RD; Zimmerman TP
J Immunopharmacol; 1982; 4(1-2):79-100. PubMed ID: 6296234
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
Bontemps F; Van den Berghe G
Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
[TBL] [Abstract][Full Text] [Related]
7. Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds. Role of adenylate deaminase.
Bennett LL; Brockman RW; Allan PW; Rose LM; Shaddix SC
Biochem Pharmacol; 1988 Apr; 37(7):1233-44. PubMed ID: 3355597
[TBL] [Abstract][Full Text] [Related]
8. 3-Deazaadenosine. S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes.
Zimmerman TP; Iannone M; Wolberg G
J Biol Chem; 1984 Jan; 259(2):1122-6. PubMed ID: 6693378
[TBL] [Abstract][Full Text] [Related]
9. Effects of calmodulin antagonists on immune mouse lymphocytes.
Wolberg G; Zimmerman TP
Mol Pharmacol; 1984 Sep; 26(2):286-92. PubMed ID: 6482875
[TBL] [Abstract][Full Text] [Related]
10. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells.
Smolenski RT; Kalsi KK; Zych M; Kochan Z; Yacoub MH
J Mol Cell Cardiol; 1998 Mar; 30(3):673-83. PubMed ID: 9515042
[TBL] [Abstract][Full Text] [Related]
11. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice.
Lukey T; Snyder FF
Biochem Pharmacol; 1983 Apr; 32(8):1399-406. PubMed ID: 6860359
[TBL] [Abstract][Full Text] [Related]
12. 3-Deazaadenosine 5'-triphosphate: a novel metabolite of 3-deazaadenosine in mouse leukocytes.
Prus KL; Wolberg G; Keller PM; Fyfe JA; Stopford CR; Zimmerman TP
Biochem Pharmacol; 1989 Feb; 38(3):509-17. PubMed ID: 2537081
[TBL] [Abstract][Full Text] [Related]
13. Effects of the S-adenosylhomocysteine hydrolase inhibitors 3-deazaadenosine and 3-deazaaristeromycin on RNA methylation and synthesis.
Backlund PS; Carotti D; Cantoni GL
Eur J Biochem; 1986 Oct; 160(2):245-51. PubMed ID: 3769925
[TBL] [Abstract][Full Text] [Related]
14. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
15. Effects of adenosine analogues on ATP concentrations in human erythrocytes. Further evidence for a route independent of adenosine kinase.
Smolenski RT; Montero C; Duley JA; Simmonds HA
Biochem Pharmacol; 1991 Oct; 42(9):1767-73. PubMed ID: 1930301
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5'-methylthioadenosine, 3-deazaadenosine, and related compounds on human natural killer cell activity. Relation to cyclic AMP and methylation potential.
Fredholm BB; Jondal M; Lanefelt F; Ng J
Scand J Immunol; 1984 Dec; 20(6):511-8. PubMed ID: 6096962
[TBL] [Abstract][Full Text] [Related]
17. Chemotaxis and the synthesis of specific proteins are inhibited by 3-deazaadenosine and other adenosine analogs in a mouse macrophage cell line.
Aksamit RR; Backlund PS; Cantoni GL
J Biol Chem; 1983 Jan; 258(1):20-3. PubMed ID: 6848495
[TBL] [Abstract][Full Text] [Related]
18. In vitro of adenosine on lymphocytes and erythrocytes from horses with combined immunodeficiency.
Magnuson NS; Perryman LE
J Clin Invest; 1979 Jul; 64(1):89-101. PubMed ID: 447864
[TBL] [Abstract][Full Text] [Related]
19. 3-Deazaadenosine-induced disorganization of macrophage microfilaments.
Stopford CR; Wolberg G; Prus KL; Reynolds-Vaughn R; Zimmerman TP
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4060-4. PubMed ID: 3858863
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
